Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Trial ID or NCT#
The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
- Any patient who carries a diagnosis of a myeloproliferative disorder (MPD).
- Any patient who is not willing to give consent.
Contact us to find out if this trial is right for you.